HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · HEK 293 cells are human embryonic kidney cells that are widely used for biotechnology and research studies. Learn about their origin, culturing, transfection, and applications in receptor signaling, protein production, cancer, and development.
BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEBBioSpace covers the latest news and trends in the life sciences industry, including biotech, pharma, gene therapy, R&D, policy and more. Find out about new launches, deals, approvals, layoffs, podcasts and special editions.
News - BioSpace
WEBBioSpace News covers the latest news and trends in the biopharmaceutical and biotechnology sectors, including deals, funding, approvals, research, policy and more. Find out what's happening in the industry with stories, analysis and …
Wet Lab vs Dry Lab: Challenges, Benefits and Skills Required
WEBJan 25, 2023 · Learn the differences between wet labs and dry labs, where testing and analyses are performed using physical samples or data, respectively. Find out the pros and cons, qualifications and structural requirements for each type of lab.
Latest News & Press Releases - BioSpace
WEBBioSpace covers the latest news and press releases from the biopharmaceutical industry, including FDA decisions, clinical trials, layoffs, and more. Browse the top stories and filter by date, keyword, and category to find relevant information.
Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More …
WEB5 days ago · BioSpace reports on the pharma and biotech layoffs in 2024, including Bayer, Tome, Aadi, Lykos and Grail. See the details, reasons and impacts of the workforce reductions and reorganizations in the industry.
With Lilly’s Zepbound Price Cut and Novo’s Impending ... - BioSpace
WEBAug 30, 2024 · Just when you thought the weight loss drug space couldn’t get any more interesting, Eli Lilly shook up the red-hot obesity market on Tuesday, stating plans to begin selling single-dose vials of its blockbuster Zepbound (tirzepatide) directly to consumers.. The announcement comes on the heels of second-quarter earnings, which showed Lilly’s Zepbound is closing the gap with Novo Nordisk’s ...
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for ...
WEBAug 14, 2024 · The European Commission on Wednesday signed off on AstraZeneca ’s combination regimen of Imfinzi (durvalumab) and Lynparza (olaparib) for the treatment of certain endometrial cancer patients with advanced or recurrent disease.. The regulatory victory marks the “first-ever approval for a combination of an immunotherapy and PARP inhibitor in endometrial cancer,” Dave Fredrickson, executive ...
Lilly Suffers Legal Loss in Tirzepatide Case Against ... - BioSpace
WEBApr 12, 2024 · A Florida judge on Tuesday dismissed Eli Lilly ’s case against a compounding pharmacy, finding that the drugmaker cannot use state law in its campaign against reformulated versions of the company’s top-selling weight-loss and diabetes medication tirzepatide.. U.S. District Judge Roy Altman wrote in his ruling that in asking the courts to bar the defendant—a compounding pharmacy named ...
Tobin Scientific Acquires BioRepository Resources - BioSpace
WEBBEVERLY, Mass., July 2, 2024 /PRNewswire/ -- Tobin Scientific, a leading provider of cold chain, ambient storage, and transport & logistics services for the life sciences industry, announced today that it has acquired BioRepository Resources LLC (BRR), a leader in biological sample storage and management solutions, located in …
Skip to content